Pioneering IVF doctor dies in Australia

September 27, 2011

A pioneering Australian doctor known for his groundbreaking work on the world's first pregnancy through in vitro fertilisation (IVF) has died after a long illness.

Carl Wood, who had battled Alzheimer's disease since 2004, passed away in a Melbourne nursing home last Friday.

Working with Melbourne's Monash University, he was a leader in the 1970s in the developing field of IVF pregnancy, heading the team that produced Australia's first test-tube baby in 1980 -- among the first in the world.

He and fellow Monash researcher Alan Trounson had earlier helped establish IVF as a method for the treatment of human infertility with the world's first clinical IVF pregnancy in 1973. However, this did not progress.

"He was at the forefront of the development of IVF technology and he led the team responsible for Australia's first IVF baby," the university said in a statement Tuesday.

"Professor Wood, with Monash University colleagues, would go on to deliver the world's first babies from and donor eggs."

The world's first baby conceived outside the human body, Louise Brown, was born in Britain in 1978 as a result of the work of IVF pioneers Patrick Steptoe and Bob Edwards.

Edwards, who was in 2010 awarded the Nobel Prize for Medicine, and Steptoe, who died in 1988, developed IVF technology in which are fertilised outside the body and implanted in the womb.

Wood's investigations into the use of artificial hormones to control the ovulation cycle of women on IVF treatment is credited with raising success rates and helping thousands of to become parents.

Former colleague Gab Kovacs said Wood's work spilled over into other areas.

"Carl pioneered the monitoring of babies during labour, which saved many, many lives," Kovacs told The Australian newspaper.

"He was also one of the first to suggest there was more to women than just their organs and pushed for the introduction of sexual counselling and abortion reform."

Related Stories

Recommended for you

Drug therapy from lethal bacteria could reduce kidney transplant rejection

August 3, 2017
An experimental treatment derived from a potentially deadly microorganism may provide lifesaving help for kidney transplant patients, according to an international study led by investigators at Cedars-Sinai.

Exploring the potential of human echolocation

June 25, 2017
People who are visually impaired will often use a cane to feel out their surroundings. With training and practice, people can learn to use the pitch, loudness and timbre of echoes from the cane or other sounds to navigate ...

Team eradicates hepatitis C in 10 patients following lifesaving transplants from infected donors

April 30, 2017
Ten patients at Penn Medicine have been cured of the Hepatitis C virus (HCV) following lifesaving kidney transplants from deceased donors who were infected with the disease. The findings point to new strategies for increasing ...

'bench to bedside to bench': Scientists call for closer basic-clinical collaborations

March 24, 2017
In the era of genome sequencing, it's time to update the old "bench-to-bedside" shorthand for how basic research discoveries inform clinical practice, researchers from The Jackson Laboratory (JAX), National Human Genome Research ...

The ethics of tracking athletes' biometric data

January 18, 2017
(Medical Xpress)—Whether it is a FitBit or a heart rate monitor, biometric technologies have become household devices. Professional sports leagues use some of the most technologically advanced biodata tracking systems to ...

Financial ties between researchers and drug industry linked to positive trial results

January 18, 2017
Financial ties between researchers and companies that make the drugs they are studying are independently associated with positive trial results, suggesting bias in the evidence base, concludes a study published by The BMJ ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.